Applied Therapeutics Inc.

NASDAQ: APLT · Real-Time Price · USD
0.48
-0.03 (-5.70%)
At close: Jul 25, 2025, 3:59 PM

Applied Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-105.62M -119.76M -82.51M -105.58M
Depreciation & Amortization
425K 354K 443K 415K
Stock-Based Compensation
13.47M 7.36M 9.6M 11.18M
Other Working Capital
-171K 1.35M -3.92M -5.15M
Other Non-Cash Items
4.91M 58.32M 3.65M -404K
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
2.52M -1.44M -8.84M 3.67M
Operating Cash Flow
-84.31M -55.17M -78.09M -90.73M
Capital Expenditures
n/a n/a n/a n/a
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a -64.22M -121.59M
Sales Maturities Of Investments
n/a 13.87M 77.39M 134.02M
Other Investing Acitivies
n/a n/a 13.17M 12.43M
Investing Cash Flow
n/a 13.87M 13.17M 12.43M
Debt Repayment
-311K -1.86M -3.27M -4.72M
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
9.37M 11.89M 3.15M 5.01M
Financial Cash Flow
113.81M 74.54M 27.69M 74.72M
Net Cash Flow
29.5M 33.24M -37.23M -3.58M
Free Cash Flow
-84.31M -55.17M -78.09M -90.73M